Predictive properties of risk assessment instruments following self-harm. by Owens, D & Kelley, R
Background
When it comes to the clinical care of people who have attended
the general hospital because of self-harm, are routine risk
assessment scales on their way out? Last year, in an editorial right
here in the BJPsych, Mulder and colleagues wrote by no means the
first obituary for risk assessment scales when they were asked,
rather as we have been, to comment on a newly published paper.1
They were weighing up a systematic review that had spun out of
the meticulous compiling and analysis that the National Institute
for Health and Care Excellence (NICE) does so well. That review
showed that none of the various risk factors (such as gender, poor
health or history of psychiatric contact), nor the three risk scales
for which they could find data (the Beck Hopelessness Scale, the
Suicide Intent Scale and the Scale for Suicide Ideation), are of
any practical value to the assessing clinician when it comes to
predicting subsequent suicide among people who have attended
hospital following self-harm.2 Chan et al said that ‘The idea of risk
assessment as risk prediction is a fallacy and should be recognised
as such’.2 The editorial writers went one step further: ‘Our current
preoccupation with risk prediction has the potential to harm
patients, clinicians and the organisations in which they work
[creating] a sense of unease among clinicians and a culture of
blame when things go wrong’.1
Mounting evidence of the poor predictive power
of risk scales
In this month’s BJPsych are two studies that take another look at
the matter: a large prospective cohort analytic study from the
UK,3 and an international collaborative systematic review with
meta-analysis.4 Again, both studies focus on psychosocial risk
scales, although rather more of them – 7 in the cohort study,
and 39 in the systematic review (from 53 separate primary
studies). The outcomes include repeated non-fatal self-harm in
both the present studies, with suicide an additional outcome in
the review. The cohort study deals only with prediction following
an episode of non-fatal self-harm whereas the systematic review
also examines the use of these scales among other psychiatric
patients. Because we already know, as above, that the notion of
there being some clinical value from this kind of risk assessment
is a fallacy, it seems inevitable that the new expanded research
would draw similar conclusions.
Within the two new research reports are many findings that
confirm the clinical futility of trying to use scales for the prediction
of suicide or repeat self-harm. For example, the psychosocial
instruments show only modest or poor positive predictive values
– 39% for self-harm plus suicide (only 28% and 4% respectively
for self-harm and suicide, if examined separately).4 Positive
predictive value is widely regarded as the measure with the most
straightforward clinical meaning – the proportion of the patients
who have tested positively (scoring above a threshold) who go on
to experience the outcome. Plainly, a 4% predictive value means
that 96% of people identified as at increased risk would not die
by suicide in the follow-up period. The predictive value for
non-fatal repetition, approaching 40% when combined with
suicide, looks considerably better but there is something illusory
about its apparent benefits when we reflect that, regardless of
any testing, around 20–30% of these patients will repeat; positive
predictive value is strongly associated with the incidence of the
outcome event, which is rare when the event is suicide but
common when it is non-fatal repetition.
The relation between positive predictive value and outcome
incidence is a further problem, acknowledged by the authors,
when pooling the predictive values in the meta-analysis. Each
primary prediction study in the review has its separate and
differing case-mix and follow-up duration, thereby rendering
the pooled predictive value one that is derived from widely
differing outcome incidences. The pooling of these values in a
validity meta-analysis is much more of a methodological problem
than it is in clinical trial meta-analysis. In a review of trials, the
main finding for each trial is a comparison between two trial arms
that have a common baseline outcome incidence, although those
outcomes may differ widely between one trial and another.
Pooling the comparison of the two arms of each trial is not
invalidated by the finding of a range of baseline outcomes. When
it comes to the pooling of predictive values in a validity meta-
analysis, however, we find that some studies researched subgroups
of patients for whom there was a high outcome incidence, and
some undertook long follow-up periods, together leading to
pooled positive predictive values that are likely to be substantially
higher than the performance level that would be expected in
regular clinical practice.4
If the systematic review looks unsupportive of risk-scaling, the
cohort study throws an even more unflattering light on the
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Summary
This month’s BJPsych publishes two important studies
concerned with the use of risk assessment scales after self-
harm, one a systematic review and the other a multicentre
cohort study. We agree with the authors: that each study
adds weight to the existing evidence that points towards
avoiding the use of such scales in clinical practice.
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predictive power of risk scales in self-harm.3 In five large English
teaching hospitals, patients referred to multidisciplinary liaison
psychiatry services for psychosocial assessment after self-harm
were administered a structured assessment that contained the
questions that make up five well-known named assessment scales
– many but not all of the items were ones routinely asked but
some additional questions needed to be included in the research
assessment interview. They also added a clinician-rated global
evaluation scale and a patient-rated version. In total, 514
patient-episodes of self-harm were assessed in this way across
the five centres – each patient contributing to the validity
appraisal of each of the seven scales – and each patient was
followed up, using the local hospital databases, for 6 months to
identify whether he or she repeated self-harm. At 30% repetition
in 6 months, the positive predictive values, using established
cut-off points, varied from a meagre 13% (the Modified SAD
PERSONS scale) to 47% for the clinician’s global scale. So, the
scales’ predictive values ranged from worse-than-useless to
providing some modest predictive advantage, although the
clinician’s rating was the scale that offered the best forecast (and
the patient’s own global rating was the next best).
The authors went on to use a technique familiar to these kinds
of evaluations: they recalculated cut-off points post hoc. That is,
they used the findings to determine the best possible cut-off
threshold for their particular study sample. It is important to
emphasise that the revised validity is thereby one that maximises
the validity metrics; if the study were repeated in another,
independently assembled sample of patients (or in the real world)
the scales would function a little or a lot worse.5 In these ideal
calculations, the self-harm prediction scales are crowded together
and provide a range of positive predictive values between 33%
and 47%; at the top end of this range of values they accomplish
no more than we saw in the systematic review.4 Another useful
way of judging validity is the plotting of receiver operating
characteristic (ROC) curves and the calculation of areas under
the curves of competing scales; the seven scales here show poor-
to-worthless performance. In short, no scale provides a reasonably
accurate prediction of repetition of self-harm.
The way forward – needs assessment
What then is to be done? The research cited above and the earlier
editorial1–4 consistently set out a clear recommendation: risk
assessment scaling should not form the basis of clinical care,
and the use of detailed risk assessment scales should be curtailed
lest they deliver false reassurance for clinicians and managers.1
National (NICE) guidelines already tell us: ‘Do not use risk
assessment tools and scales to predict future suicide or repetition
of self-harm [or] to determine who should or should not be
offered treatment or who should be discharged’6 – yet use of these
tools remains widespread.7 Instead, thorough psychosocial
assessment is recommended after self-harm – to ‘move away from
assessment models that prioritise risks at the expense of needs’2
and to focus on the person and the particular circumstances,
characteristics and meanings that seem likely to have precipitated
his or her suicidal ideation and behaviour. Needs assessment is a
sufficiently apt term for such an approach and it is probably much
closer to what patients actually want.
Evidence, largely qualitative, about recipients’ views of the
psychosocial assessment process offers some straightforward
messages, although what people think specifically about being in
receipt of risk-scaling is not known. There are copious reports
of dissatisfaction with any sense of being processed, with stock
questions in particular deemed to constitute a superficial
assessment, for example: ‘I could say, ‘‘how are you feeling
now?’’ and get paid for it . . . in that sort of work you’ve got to
have your own opinions and I think that’s what makes the better
ones that don’t stick to the standard questions, yes and no
answers;’8 and ‘it’s like they’re pre-programmed to ask these
questions irrespective, you could go with your head dropping
off and they’d still be asking these questions’.8
It is plain that patients want a space where it is safe to be
emotionally distressed while retaining some sense of privacy.8
When it comes to investigations, physical or psychological, people
want clear explanations of why they are being done, what is
involved, what the findings and implications are, and want to discuss
what further symptoms they might expect as a consequence of the
self-harm and of any treatment given.8 People also want to share
in decision-making about their future care, with reasonable
attention paid to their personal preferences.9,10 It is not that
people who have attended hospital as a consequence of self-harm
want distinct or exceptional treatment. Instead, they want the
same level of clinical care that might be expected by anyone else
in the emergency department or general ward, delivered with
the same level of openness, warmth and respect – although
accompanied by acknowledgement of their fragile emotional state.
They also want assurance that they are not viewed as time-wasters
or attention-seekers.11 Care delivery, including the psychosocial
assessment process, needs to be sufficiently compassionate. People
are relieved to have their painful mental state taken seriously and
when the nurse or doctor legitimises feelings of distress, it can be a
first step in dealing with the intense negative emotions that
preceded the self-harm.12 People who have self-harmed know that
there will be some routine questioning and a necessary assessment
process before they can go home12 and they know it will be
required before arrangements that they hope will be helpful can
be put in place: ‘[I’m] hugely grateful that I’ve got the help, it’s
made a whole world of difference . . . people are phoning me,
keeping me informed, my care people are coming, I know that
within the next couple of weeks, I will have the support I need’.12
Unfortunately, there is a substantial flaw in any recommendation
concerned with improvements in the quality and focus of psycho-
social assessments, revealed by a recent survey of hospital services
for self-harm in 32 hospitals in England by Cooper and colleagues.13
The study reveals a sad state of affairs regarding hospital services
for self-harm: the median figure for the proportion of people
receiving a psychosocial assessment from a mental health
professional following self-harm was only 58%, and was as low
as 22% at worst – worrying rates given the strong links between
self-harm and subsequent suicide. This survey was a re-evaluation
of the same hospitals in a similar survey almost 10 years earlier
and there seemed to have been no improvement on the low levels
of adequate assessment seen then, although there was some
evidence of improved service structures. Further corroboration
of this habitual deficiency in the services in England can be found
in the present cohort study:3 in the teaching hospitals where the
research was carried out, psychosocial assessment was only
received by 45% to 77% of people. It is hard to see how a focus
on individual patients’ needs, as recommended here and
elsewhere, can be achieved when many (and in some places most)
patients do not receive an assessment at all, let alone a proper
evaluation of those needs.
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The Counterfeiters by Andre´ Gide
Alistair Stewart
Sexuality (homo and hetero), youth and age, seduction, corruption, religion, respectability and hypocrisy, uncertain parentage,
masturbation, innocence and cynicism, adultery, mental illness, art, appearance and reality, suicide, partying and self-discovery
– Andre´ Gide packed all this into The Counterfeiters, his novel of 1925, set among the Parisian bourgeoisie of the early 20th
century. One innocent caught up in this tangled and dangerous web is a vulnerable, troubled and lovable boy of 13 called Boris.
His mother is a highly strung travelling singer; his father the man with whom she eloped, but who is now dead; he is pined for by
a grandfather, an ailing, unhappy man who has never seen him. Boris has been entrusted to the care of a Polish psychoanalyst,
Mme Sophroniska, who is trying to release him from a state of regressed and erratic behaviour accompanied by a private
language. She in turn describes her daughter Bronja, with whom Boris has formed an intense bond, as his ‘real doctor’.
The character of Sophroniska is based on the Polish psychoanalyst Eugenia Sokolnicka, pupil of Jung and analysand of Freud in
Vienna, and then, more successfully, of Ferenczi in Budapest. A complex personality, she became a key figure in the introduction
of Freud’s methods into France and a pioneer of child psychoanalysis. She was known to Andre´ Gide and treated him, although
he only attended for six sessions; possibly he was only seeking material for his writings. He certainly drew for Boris’s story on
some superficial details of Sokolnicka’s account, published in 1920, of her analysis of a 10-year-old boy with an obsessional
neurosis. And although the cases of the real and the fictional child are quite different, there are clear echoes in Sophroniska’s
approach of Sokolnicka’s careful, undogmatic and practical method, and her emphasis on the importance of basic sex education,
as reflected in her paper, which incidentally is not difficult to find.
Sophroniska is described by Edouard, a somewhat ambiguous and morally complacent author, who meets her and Boris and
Bronja at a resort in the Swiss Alps. She gently teases him about his artistic pretensions, and explains her own procedure as
follows: ‘My role is to allow things to emerge, and above all not to suggest anything. This requires extraordinary patience’.
Her elucidation and formulation of Boris’s troubles, her treatment of him, and what subsequently happens to Boris and Bronja,
form an important strand in the novel and are central to its denouement.
The title alludes to a case of circulating forged money, but also clearly has a wider resonance. As often in life, young people
suffer because of the selfish, hypocritical or thoughtless behaviour of their elders; certain more cynical and malevolent
individuals induce impressionable children and adolescents to do their dirty work, while keeping their own hands clean. At
the same time Gide is unsentimental about how cruel children can be. It is one thing to cure a child of a neurosis, quite another
to protect them from the dangers of the outside world.
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